| Serial Number | 77345125 |
| Word Mark | KUROGRAFT |
| Filing Date | Wednesday, December 5, 2007 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, July 7, 2017 |
| Registration Number | 3882001 |
| Registration Date | Tuesday, November 30, 2010 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 9, 2010 |
| Goods and Services | Cosmetic products, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cement, which contain hormones and/or growth factors to support restoration and reconstruction in reconstructive or cosmetic surgery; materials for permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous soft tissue, in particular fatty tissue and muscle tissue, other than for medical purposes, namely, protein and/or peptide and/or polyalkylenoxide preparations; carrier materials of synthetic and/or natural origin for cosmetic purposes, namely, matrices, solutions, gels, pastes, microparticles, nanoparticles, beads and cements, in particular consisting of fibrin and/or polyethylene glycol for retention or increased release of peptides or proteins, in particular hormones and growth factors, i.e., substances which stimulate growth of an organism or maintain growth for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; pharmaceutical products and preparations, namely, protein and/or peptide preparations, in particular for locally supporting the formation or regeneration of missing or damaged body parts, in particular of hard or soft tissue, in particular skin or bone; pharmaceutical or medical formulations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements of synthetic and/or natural origin for medical purposes, namely, for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue, in particular comprising fibrin and/or polyoxyalkyleneoxides, namely, polyethylene glycol for retention or sustained release of peptides, proteins and/or allograft materials, in particular hormones, growth factors and/or demineralized bone matrix, i.e., substances which stimulate growth of an organism or maintain growth; healthcare preparations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; biomedical products and biotechnology products for medical purposes, namely, peptides and proteins like hormones and growth factors or allograft materials used to spur regrowth and formation and to repair tissue, namely, tissue of bone, skin, organs, tendons, ligament, cartilage; materials for medical purposes for permanent or temporary enlargement, filling, repair, stabilization, support and/or regeneration of hard or soft tissue, in particular bone, intervertebral disk, cartilage, fatty tissue and muscle tissue, namely, protein and/or peptide and/or polyalkylenoxide preparations; biocompatible permanent or temporary adhesives and sealants, in particular for human and animal organs, soft and hard tissue for medical purposes; biocompatible separating materials, namely, anti-adhesion materials for avoiding undesired adhesion of organs and/or soft parts for medical purposes; implants and transplants of human derived autologous or allograft materials; autologous and allograft soft tissue for cosmetic and medical purposes; autologous and allograft hard and soft tissue in particular bone for transplantation purposes, bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement |
| Goods and Services | Artificial tissue replacement for restoring, maintaining and/or improving the function of diseased or damaged human or animal tissue (tissue engineering); synthetic implants, and transplants and modified implants and transplants, tissue, cells and/or molecules for replacing and/or for supporting the function of missing or damaged body parts; synthetic hard and soft tissue, in particular synthetic bone for transplantation purposes and diagnostic purposes, synthetic bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement; modified implants and transplants with engineered endogenous material, tissue, cells or molecules for replacing and/or for supporting the function of missing or damaged body parts |
| Pseudo Mark | KUROS GRAFT |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, July 7, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, July 7, 2017 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kuros Biosurgery AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Zürich 8005 CH |
| Party Name | Kuros Biosurgery AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Zürich 8005 CH |
| Party Name | Kuros Biosurgery AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Zürich 8005 CH |
| Event Date | Event Description |
| Friday, July 7, 2017 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, November 30, 2010 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, October 21, 2010 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| Thursday, October 21, 2010 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Tuesday, October 19, 2010 | NOTICE OF ALLOWANCE CANCELLED |
| Wednesday, October 20, 2010 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, October 20, 2010 | ASSIGNED TO PETITION STAFF |
| Tuesday, October 19, 2010 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Tuesday, October 19, 2010 | TEAS PETITION TO AMEND BASIS RECEIVED |
| Tuesday, May 4, 2010 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 9, 2010 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 9, 2010 | PUBLISHED FOR OPPOSITION |
| Thursday, January 7, 2010 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, January 7, 2010 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, December 17, 2009 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 17, 2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 17, 2009 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 21, 2009 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, July 21, 2009 | NON-FINAL ACTION E-MAILED |
| Tuesday, July 21, 2009 | NON-FINAL ACTION WRITTEN |
| Saturday, May 23, 2009 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, May 23, 2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, May 21, 2009 | ASSIGNED TO LIE |
| Thursday, May 21, 2009 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, May 21, 2009 | EX PARTE APPEAL-INSTITUTED |
| Thursday, May 21, 2009 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Thursday, May 21, 2009 | EXPARTE APPEAL RECEIVED AT TTAB |
| Friday, November 21, 2008 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, November 21, 2008 | FINAL REFUSAL E-MAILED |
| Friday, November 21, 2008 | FINAL REFUSAL WRITTEN |
| Friday, November 7, 2008 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 7, 2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 7, 2008 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, September 25, 2008 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, September 25, 2008 | LETTER OF SUSPENSION E-MAILED |
| Thursday, September 25, 2008 | SUSPENSION LETTER WRITTEN |
| Tuesday, September 16, 2008 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 16, 2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 16, 2008 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 17, 2008 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 17, 2008 | NON-FINAL ACTION E-MAILED |
| Monday, March 17, 2008 | NON-FINAL ACTION WRITTEN |
| Friday, March 14, 2008 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Friday, March 14, 2008 | ASSIGNED TO EXAMINER |
| Tuesday, December 11, 2007 | NOTICE OF PSEUDO MARK MAILED |
| Monday, December 10, 2007 | NEW APPLICATION ENTERED IN TRAM |